AMTAR researchers were delighted to attend and support iSRS2025 at the Gold Coast. In addition to presenting research, the conference was a fantastic opportunity to connect with industry partners and researchers from across the world, including a team from AMTAR partner Oak Ridge National Laboratory.

It was a particular privilege to sponsor the conference Poster Awards, with two prizes awarded to the best ECR posters. AMTAR Chief Investigator Assoc Prof  Brett Paterson was on the judging panel and presented the awards to the winner, Nadia Pederson, Copenhagen University and runner up, Rachel Payne, Memorial Sloan Kettering Cancer Center.

AMTAR associate HDR student, Uma Maheshwari Bharathi, was awarded an AMTAR travel award to support attendance at iSRS and has shared her experience of the conference:

“I had the incredible opportunity to attend the 26th International Symposium on Radiopharmaceutical Sciences (iSRS) 2025, organised by the Society of Radiopharmaceutical Sciences (SRS), held at the beautiful city of Gold Coast, thanks to the generous support from the AMTAR Travel Grant. As a biologist working on a project involving targeted alpha therapy, this conference was a truly enriching experience – it gave me a much better clearer understanding of the radiopharmaceutical and nuclear medicine aspects of my research. I presented a poster titled “Initial investigations into Nanobody functionalisation and radiolabeling with Astatine-211”, and the feedback and discussions it sparked were both insightful and encouraging. Engaging with researchers from diverse backgrounds – radiochemistry, biology, imaging,and translational research – really helped me see where my work fits in the broader field of targeted radionuclide therapy. The conference not only expanded my technical knowledge but also left me more inspired and confident in the interdisciplinary direction of my project.”

Oral presentations:

Dr James Humphries “Evaluating mRNA delivery using nuclear medicine”
Dr Nicholas Fletcher “Pre-targeting of PEG-based nanomedicines: precise delivery of potent payloads”

Poster presentations:

Uma Maheshwari Bharathi “Initial Investigations into Nanobody Functionalization and Radiolabeling with Astatine-211”
Dr James Wood “D2 – Enabling a theranostic approach with 89Zr/177Lu in a single trifunctional ligand scaffold”
A/Prof Brett Paterson & Dr Melyssa Grieve “Developing a new chelator for the rapid and stable complexation of the α-generators 212Bi and 212Pb”
Dr Callum Rosser “The chemoenzymatic assembly of hydroxamic acid radiochemical ligands with an amine chemical handle”
Dr Pie Huda “Optimising VHH-Based Radiopharmaceuticals: Addressing Pharmacokinetics and Renal Clearance Challenges”